Pathological changes related to Imatinib treatment in a patient with a metastatic gastrointestinal stromal tumour

This publication has 11 references indexed in Scilit:

• Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
  Journal of Clinical Oncology, 2003
• Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients
  British Journal of Cancer, 2003
• Images in Pathology
  International Journal of Surgical Pathology, 2003
• Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with imatinib
  Pathology and Oncology Research, 2003
• Complete remission of a metastatic gastrointestinal stromal tumour with the tyrosine kinase inhibitor imatinib (STI 571)
  European Journal of Gastroenterology & Hepatology, 2003
• The reappraisal of gastrointestinal stromal tumors: from Stout to the KIT revolution
  Virchows Archiv, 2003
• Pharmacotherapy of gastrointestinal stromal tumours
  Expert Opinion on Pharmacotherapy, 2003
• Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
  New England Journal of Medicine, 2002
• Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
  The Lancet, 2001
• Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor
  New England Journal of Medicine, 2001